These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16162629)

  • 21. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
    Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
    Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
    ; Armstrong PW; Granger CB; Adams PX; Hamm C; Holmes D; O'Neill WW; Todaro TG; Vahanian A; Van de Werf F
    JAMA; 2007 Jan; 297(1):43-51. PubMed ID: 17200474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of one-year outcome of patients aged <75 years versus ≥75 years undergoing "rescue" percutaneous coronary intervention.
    De Felice F; Fiorilli R; Parma A; Musto C; Nazzaro MS; Confessore P; Scappaticci M; Cifarelli A; Violini R
    Am J Cardiol; 2011 Oct; 108(8):1075-80. PubMed ID: 21791331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of an early invasive strategy after fibrinolysis in ST-elevation myocardial infarction relative to the extent of coronary artery disease.
    Elbarouni B; Cantor WJ; Ducas J; Borgundvaag B; Džavík V; Heffernan M; Buller CE; Langer A; Goodman SG; Yan AT;
    Can J Cardiol; 2014 Dec; 30(12):1555-61. PubMed ID: 25475460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early routine angioplasty versus selective angioplasty after successful thrombolysis in acute ST-segment elevation myocardial infarction.
    Geng W; Tian X; Fu X; Wang P; Wang Y; Wang X; Li W; Liu X
    Coron Artery Dis; 2013 May; 24(3):238-43. PubMed ID: 23358446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of the viability guided angioplasty after acute myocardial infarction (VIAMI) trial.
    van Loon RB; Veen G; Baur LH; Twisk JW; van Rossum AC
    Int J Cardiol; 2015; 186():111-6. PubMed ID: 25814356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.
    Sejersten M; Birnbaum Y; Ripa RS; Maynard C; Wagner GS; Clemmensen P;
    Heart; 2006 Nov; 92(11):1577-82. PubMed ID: 16740918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
    Singh HS; Dangas GD; Guagliumi G; Yu J; Witzenbichler B; Kornowski R; Grines C; Gersh B; Dudek D; Mehran R; Stone GW
    Am J Cardiol; 2012 Oct; 110(7):940-7. PubMed ID: 22748356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study.
    Savonitto S; De Servi S; Petronio AS; Bolognese L; Cavallini C; Greco C; Indolfi C; Visconti LO; Piscione F; Ambrosio G; Galvani M; Marzocchi A; Santilli I; Steffenino G; Maseri A
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):217-26. PubMed ID: 18301136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial).
    Sejersten M; Ripa RS; Maynard C; Wagner GS; Andersen HR; Grande P; Mortensen LS; Clemmensen P
    Am J Cardiol; 2006 Mar; 97(5):611-6. PubMed ID: 16490423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
    Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).
    Kotowycz MA; Cosman TL; Tartaglia C; Afzal R; Syal RP; Natarajan MK
    Am Heart J; 2010 Jan; 159(1):117.e1-6. PubMed ID: 20102876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
    Boden H; van der Hoeven BL; Liem SS; Atary JZ; Cannegieter SC; Atsma DE; Bootsma M; Jukema JW; Zeppenfeld K; Oemrawsingh PV; van der Wall EE; Schalij MJ
    EuroIntervention; 2012 Jan; 7(9):1021-9. PubMed ID: 22207227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
    Yusuf S; Mehta SR; Chrolavicius S; Afzal R; Pogue J; Granger CB; Budaj A; Peters RJ; Bassand JP; Wallentin L; Joyner C; Fox KA;
    JAMA; 2006 Apr; 295(13):1519-30. PubMed ID: 16537725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
    Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
    Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial.
    Kaltoft A; Kelbaek H; Kløvgaard L; Terkelsen CJ; Clemmensen P; Helqvist S; Lassen JF; Thuesen L
    J Am Coll Cardiol; 2010 Mar; 55(9):867-71. PubMed ID: 20185036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up.
    Politi L; Sgura F; Rossi R; Monopoli D; Guerri E; Leuzzi C; Bursi F; Sangiorgi GM; Modena MG
    Heart; 2010 May; 96(9):662-7. PubMed ID: 19778920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
    Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
    J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.